Probiotic and prebiotic influence beyond the intestinal tract

Nutrition Reviews

Volumn 65, Issue 11, 2007, Pages 469-489

  Lenoir Wijnkoop, Irene ^a   Sanders, Mary Ellen ^b   Cabana, Michael D ^c   Caglar, Esber ^d   Corthier, Gerard ^e   Rayes, Nada ^f   Sherman, Philip M ^g   Timmerman, Harro M ^h,l   Vaneechoutte, Mario ⁱ   Loo, Jan Van ^j   Wolvers, Danielle A W ^k  

^a DANONE RESEARCH   (France)

^b DAIRY AND FOOD CULTURE TECHNOLOGIES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d YEDITEPE UNIVERSITY   (Turkey)

^e CEMAGREF   (France)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g UNIVERSITY OF TORONTO   (Canada)

^h WINCLOVE PROBIOTICS   (Netherlands)

ⁱ GHENT UNIVERSITY   (Belgium)

^j ORAFTI   (Belgium)

^k UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^l UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

more..

Author keywords

Microbiota; Prebiotic; Probiotic

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH CITRATE; LACTOBACILLUS CASEI EXTRACT; LACTOBACILLUS REUTERI EXTRACT; LACTOBACILLUS RHAMNOSUS EXTRACT; LACTOBACILLUS ZEAE EXTRACT; METRONIDAZOLE; OMEPRAZOLE; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; REACTIVE OXYGEN METABOLITE; STOMACH SECRETION INHIBITOR; SYNBIOTIC AGENT; TETRACYCLINE;

ABDOMINAL SURGERY; ABSENTEEISM; ACUTE DIARRHEA; ACUTE DISEASE; ALLERGIC RHINITIS; ALLERGY; ANTINEOPLASTIC ACTIVITY; ASTHMA; ATOPIC DERMATITIS; ATOPY; BIFIDOBACTERIUM; BONE DENSITY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMMON COLD; CONTROLLED CLINICAL TRIAL; DAILY LIFE ACTIVITY; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG MECHANISM; DRUG RESEARCH; ERADICATION THERAPY; GYNECOLOGIC CANCER; HEALTH CARE COST; HELICOBACTER INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTIOUS DIARRHEA; INTERMETHOD COMPARISON; LACTOBACILLUS; LACTOBACILLUS REUTERI; MICROBIAL ACTIVITY; MICROBIAL ADHESION; MICROBIAL COLONIZATION; MICROBIAL GROWTH; MILK ALLERGY; MONOTHERAPY; MOUTH INFECTION; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITIONAL ASSESSMENT; OUTCOME ASSESSMENT; PANCREAS NECROSIS; PANCREATITIS; PATHOGENESIS; PEPTIC ULCER; PERIODONTITIS; POLLEN ALLERGY; PREVALENCE; RESPIRATORY TRACT INFECTION; REVIEW; SOCIOECONOMICS; STOMACH ADENOCARCINOMA; STREPTOCOCCUS MUTANS; STREPTOCOCCUS THERMOPHILUS; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; UROGENITAL TRACT INFECTION; ANIMAL; CHICKEN; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM; FEMALE; HYPERSENSITIVITY; IMMUNE SYSTEM; IMMUNOLOGY; MALE; MICROBIOLOGY; RANDOMIZED CONTROLLED TRIAL; RAT; RESPIRATORY SYSTEM; UROGENITAL SYSTEM;

ANIMALS; CHICKENS; DIETARY SUPPLEMENTS; DIGESTIVE SYSTEM; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNE SYSTEM; MALE; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RATS; RESPIRATORY SYSTEM; UROGENITAL SYSTEM;

EID: 38449091386     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1301/nr.2007.nov.469-489     Document Type: Review

References (143)

1. Macfarlane S, Macfarlane GT, Cummings JH. Review article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther 2006 24 : 701 714.
2. de Vrese M, Marteau PR. Probiotics and prebiotics: effects on diarrhea. J Nutr 2007 137 : 803 811.
3. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006 124 : 837 848.
4. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006 444 : 1022 1023.
5. Strober W. Immunology: unraveling gut inflammation. Science 2006 313 : 1052 1054.
6. Gibson GR, Rastall RA. Prebiotics: Developments and Application. Hoboken, NJ : Wiley 2006 : 1 264.
7. Gibson GR., Probert HM, Van Loo J, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004 17 : 259 275.
8. Taper HS, Roberfroid M. Influence of inulin and oligofructose on breast cancer and tumor growth. J Nutr 1999 129 : 1488 1491.
9. Taper HS, Delzenne NM, Roberfroid MB. Growth inhibition of transplantable mouse tumors by non-digestible carbohydrates. Int J Cancer 1997 71 : 1109 1112.
10. Pierre F, Perrin P, Champ M, Bornet F, Meflah K, Menanteau J. Short-chain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in Min mice. Cancer Res 1997 57 : 225 228.
11. Rafter J, Bennett M, Caderni G, et al. Dietary synbiotics reduce cancer risk factors in polypec-tomized and colon cancer patients. Am J Clin Nutr 2007 85 : 488 496.
12. Scholz-Ahrens KE, Acil Y, Schrezenmeir J. Effect of oligofructose or dietary calcium on repeated calcium and phosphorus balances, bone mineralization and trabecular structure in ovariectomized rats. Br J Nutr 2002 88 : 365 377.
13. Roberfroid MB, Cumps J, Devogelaer JP. Dietary chicory inulin increases whole-body bone mineral density in growing male rats. J Nutr 2002 132 : 3599 3602.
14. Roller M, Rechkemmer G, Watzl B. Prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobac-terium lactis modulates intestinal immune functions in rats. J Nutr 2004 134 : 153 156.
15. Firmansyah A, Pramita G, Fassler C, Haschke F, Link-Amster H. Improved humoral immune response to measles vaccine in infants receiving infant cereal with fructooligosaccharides. J Paed Gastr Nutr 2001 31.
16. Cani PD, Joly E, Delzenne N. Oligofrucotse promotes satiety in healthy human volunteers: a pilot study. Eur J Clin Nutr 2006 60 : 567 572.
17. Scheppach W, Luehrs H, Menzel T. Beneficial health effects of low-digestible carbohydrate consumption. Br J Nutr 2001 85 : 23 30.
18. Bongaerts G, Severijnen R, Timmerman H. Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy. Med Hypotheses 2005 64 : 64 68.
19. Yusrizal X, Chen TC. Effect of adding chicory fruc-tans in feed on fecal and intestinal flora. Int J Poultry Sci 2003 2 : 188 194.
20. Yusrizal X, Chen TC. Effect of adding chicory fruc-tans in feed on broiler growth performance serum cholesterol and intestinal length. Int J Poultry Sci 2003 2 : 214 219.
21. Flickinger EA, Van Loo J, Fahey GC Jr. Nutritional responses to the presence of inulin and oligofructose in the diets of domesticated animals: a review. Crit Rev Food Sci Nutr 2003 43 : 19 60.
22. Caglar E, Kargul B, Tanboga I. Bacteriotherapy and probiotics' possible role on oral health. Oral Diseases 2005 11 : 131 137.
23. Çaglar E, Kavaloglu S, Ergeneli S, Sandalli N, Twetman S. Salivary mutans streptococci and lac-tobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55730 by straws or tablets. Acta Odont Scand 2006 64 : 314 318.
24. Näse L, Hatakka K, Savilahti E, et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res 2001 35 : 412 420.
25. Çaglar E, Sandalli N, Twetman S, Kavaloglu S, Ergeneli S, Selvi S. Effect of yogurt with Bifidobac-terium DN-173 010 on salivary mutans streptococci and lactobacilli in young adults. Acta Odon-tol Scand 2005 63 : 317 320.
26. Becker MR, Paster BJ, Leys EJ, et al. Molecular analysis of bacteria species associated with childhood caries. J Clin Microbiol 2002 40 : 1001 1009.
27. Modesto M, Biavati B, Mattarelli P. Occurrence of the family bifidobacteriaceae in human dental caries and plaque. Caries Res 2006 40 : 271 276.
28. Hillman JD, Brooks TA, Mickalek SM, et al. Construction and characterization of an effector strain of Streptococcus mutans for replacement therapy of dental caries. Infect Immun 2000 68 : 543 549.
29. Krüger C, Hu Y, Pan Q, et al. In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nature Biotechnol 2002 20 : 702 706.
30. Smith DJ, King WF, Rivero J, Taubman MA. Immu-nological and protective effects of diepitopic sub-unit dental caries vaccines. Infect Immun 2005 73 : 2797 2804.
31. Al-Zahrani MS. Increased intake of dairy products is related to lower periodontitis prevalence. J Peri-odontol 2006 77 : 289 294.
32. Ernst P, Peura DA, Crowe SE. The translation of Helicobacter pylori basic research to patient care. Gastroenterology 2006 130 : 188 2006.
33. Falkow S. Is persistent bacterial infection good for your health Cell 2006 124 : 699 702.
34. Matysiak-Budnik T, Megraud F. Helicobacter pylori infection and gastric cancer. Eur J Cancer 2006 42 : 708 716.
35. Sherman PM, Lin FYH. Extradigestive manifestions of Helicobacter pylori infection in children and adolescents. Can J Gastroenterol 2005 19 : 421 424.
36. Johnson-Henry KC, Mitchell DJ, Avitzur Y, Gal-indo-Mata E, Jones NL, Sherman PM. Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Dig Dis Sci 2004 49 : 1095 1102.
37. Hamilton-Miller JMT. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrob Agents 2003 22 : 360 366.
38. Bleich A, Mahler M. Environment as a critical factor for the pathogenesis and outcome of gastrointestinal disease: experimental and human inflammatory bowel disease and Helicobacter-induced gastritis. Pathobiology 2005 72 : 293 307.
39. Gotteland M, Brunser O, Cruchet S. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori Aliment Pharmacol Therap 2006 23 : 1077 1086.
40. Szajewska H, Setty M, Mrukowicz J, Guandalini S. Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of efficacy. J Pe-diatric Gastroenterol Nutr 2006 42 : 454 475.
41. Sheu BS, Cheng HC, Kao AW, et al. Pretreatment with Lactobacillus- and Bifidobacterium-contain-ing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy. Am J Clin Nutr 2006 83 : 864 869.
42. Bhatia M, Wong FL, Cao Y, et al. Pathophysiology of acute pancreatitis. Pancreatology 2005 5 : 132 144.
43. Bhatia M, Neoptolemos JP, Slavin J. Inflammatory mediators as therapeutic targets in acute pancreatitis. Curr Opin Investig Drugs 2001 2 : 496 501.
44. Gloor B, Todd KE, Lane JS, Rigberg DA, Reber HA. Mechanism of increased lung injury after acute pancreatitis in IL-10 knockout mice. J Surg Res 1998 80 : 110 114.
45. McKay CJ, Imrie CW. The continuing challenge of early mortality in acute pancreatitis. Br J Surg 2004 91 : 1243 1244.
46. Van Laethem JL, Eskinazi R, Louis H, Rickaert F, Robberecht P, Deviere J. Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut 1998 43 : 408 413.
47. Dugernier TL, Laterre PF, Wittebole X, et al. Com-partmentalization of the inflammatory response during acute pancreatitis: correlation with local and systemic complications. Am J Respir Crit Care Med 2003 168 : 148 157.
48. Van der Poll T. Immunotherapy of sepsis. Lancet Infect Dis 2001 1 : 165 174.
49. Gloor B, Muller CA, Worni M, Martignoni ME, Uhl W, Buchler MW. Late mortality in patients with severe acute pancreatitis. Br J Surg 2001 88 : 975 979.
50. Olah A, Belagyi T, Issekutz A, Gamal ME, Beng-mark S. Randomized clinical trial of specific lactobacillus and fiber supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 2002 89 : 1103 1107.
51. Besselink MG, Timmerman HM, Buskens E, Nieuwenhuijs VB, Akkermans LM, Gooszen HG. Probi-otic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial [ISRCTN38327949]. BMC Surg 2004 4 : 12.
52. Zeuzem S. Gut-liver axis. Int J Colorectal Dis 2000 15 : 59 82.
53. Salaspuro F, Nyfors S, Heine R, et al. Ethanol oxidation and acetaldehyde production in vitro by human intestinal strains of Escherichia coli under aerobic, microaerobic, and anaerobic conditions. Scand J Gastroenterol 1999 34 : 967 973.
54. Kaplowitz N. Mechanisms of liver cell injury. J Hepatol 2000 32 : 39 47.
55. Li Z, Yang S, Lin H, et al. Probiotics and antibodies to TNF inhibit inflammatory actvity and improve nonalcoholic fatty liver disease. Hepatology 2003 37 : 343 350.
56. Loguercio C, DeSimone T, Frederico A, et al. Gut-liver axis: a new point of attack to treat chronic liver damage [Letter to the Editor] AJG 2002 97 : 2144 2146.
57. Loguercio C, Federico A, Tuccillo C, et al. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol 2005 39 : 540 543.
58. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004 39 : 1441 1449.
59. Wade JJ, Rolando N, Hayller K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation. An analysis of 284 patients. Hepatology 1995 21 : 1326 1336.
60. Wacha H, Hau T, Dittmer R, Ohmann C. Risk factors associated with intraabdominal infections: a prospective multicenter study. Langenbecks Arch Surg 1999 384 : 24 32.
61. Rayes N, Seehofer D, Hansen S, et al. Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 2002 74 : 123 128.
62. Rayes N, Hansen S, Seehofer D, et al. Early enteral supply of fiber and lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition 2002 18 : 609 615.
63. Rayes N, Seehofer D, Theruvath T, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - a randomized, double-blind trial. Am J Transplant 2005 5 : 125 130.
64. Mittal RD, Kumar R, Mittal B, Prasad R, Bhandari M. Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Ox-alobacter formigenes as risk factors for renal stone formation. Med Princ Pract 2003 12 : 208 213.
65. Stewart CS, Duncan SH, Cave DR. Oxalobacter formigenes and its role in oxalate metabolism in the human gut. FEMS Microbiol Lett 2004 230 : 1 7.
66. Sidhu H, Allison MJ, Chow JM, Clark A, Peck AB. Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formi-genes. J Urol 2001 166 : 1487 1491.
67. Giorgi A, Torriani S, Dellaglio F, Bo G, Stola E, Bernuzzi L. Identification of vaginal lactobacilli from asymptomatic women. Microbiologica 1987 10 : 377 384.
68. Verhelst R, Verstraelen H, Claeys G, et al. Comparison between Gram stain and culture for the characterization of vaginal microflora: definition of a distinct grade that resembles grade I microflora and revised categorization of grade I microflora. BMC Microbiol 2005 5 : 61.
69. Reid G, McGroarty JA, Tomeczek L, Bruce AW. Identification and plasmid profiles of Lactobacillus species from the vagina of 100 healthy women. FEMS Immunol Med Microbiol 1996 15 : 23 26.
70. Anukam KC, Osazuwa EO, Ahonkhai I, Reid G. Lactobacillus vaginal microbiota of women attending a reproductive health care service in Benin city, Nigeria. Sex Transm Dis 2006 33 : 59 62.
71. 2-producing lactobacilli and vaginal Esche-richia coli colonization in women with recurrent urinary tract infections. J Infect Dis 1998 178 : 446 450.
72. Reid G, Seidenfeld A. Drug resistance amongst uropathogens isolated from women in a suburban population: laboratory findings over 7 years. Can J Urol 1997 4 : 432 437.
73. Boris S, Suarez JE, Vazquez F, Barbes C. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun 1998 66 : 1985 1989.
74. Falagas ME, Betsi GI, Tokas T, Athanasiou S. Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies. Drugs 2006 66 : 1253 1261.
75. Kaewsrichan J, Peeyananjarassri K, Kongprasert-kit J. Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens. FEMS Immunol Med Microbiol 2006 48 : 75 83.
76. Boskey ER, Cone RA, Whaley KJ, Moench TR. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod 2001 16 : 1809 1813.
77. Vallor AC, Antonio MA, Hawes SE, Hillier SL Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. J Infect Dis 2001 184 : 1431 1436.
78. Famularo G, Pieluigi M, Coccia R, Mastroiacovo P, De Simone C. Microecology, bacterial vaginosis and probiotics: perspectives for bacteriotherapy. Med Hypotheses 2001 56 : 421 430.
79. Pybus V, Onderdonk AB. Microbial interactions in the vaginal ecosystem, with emphasis on the pathogenesis of bacterial vaginosis. Microbes Infect 1999 1 : 285 292.
80. Antonio MAD, Hillier SL DNA fingerprinting of Lactobacillus crispatus strain CTV-05 by repetitive element sequence-based PCR analysis in a pilot study of vaginal colonization. J Clin Microbiol 2003 41 : 1881 1887.
81. Osset J, Bartolome RM, Garcia E, Andreu A. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis 2001 183 : 485 491.
82. Rousseau V, Lepargneur JP, Roques C, Remaud-Simeon M, Paul F. Prebiotic effects of oligosac-charides on selected vaginal lactobacilli and pathogenic microorganisms. Anaerobe 2005 11 : 145 153.
83. Loeser A. Der Fluor, seine Entstehung und eine kausale Therapie mittels des Bakterienpreparates "Bazillosan Zbl Gynäkol 1920 17 : 417 429.
84. Anukam K, Osazuwa E, Ahonkhai I, et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infection 2006 8 : 1450 1454.
85. Anukam KC, Osazuwa E, Osemene GI, Ehigiagbe F, Bruce AW, Reid G. Clinical study comparing probiotic lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infection 2006 8 : 1 5.
86. Siboulet A. Vaccination against nonspecific bacterial vaginosis. Double-blind study of Gynatren. Gynäkol Rundsch 1991 31 : 153 160.
87. Eschbach W, Kludas M. Survival in human vagina of living, lyophilized Doederlein bacillus on cottonwool tampons. Ärtzliche Wochenschrift 1957 12 : 739 742.
88. Bandera Gonzalez B, Conde de Vargas BI, Gonzalez Avalos GA, Toledo Medina A. Treatment of non-specific cervicovaginitis with a lyophilized preparation of lactobacilli and estriol. Prensa Med Mex 1977 42 : 91 95.
89. Neri A, Sabah G, Samra Z. Bacterial vaginosis in pregnancy treated with yoghurt. Acta Obstet Gy-necol Scand 1993 72 : 17 19.
90. Hallen A, Jarstrand C, Pahlson C. Treatment of bacterial vaginosis with lactobacilli. Sex Transm Dis 1992 19 : 146 148.
91. Delia A, Morgante G, Rago G, Musacchio MC, Petraglia F, De Leo V. Effectiveness of oral administration of Lactobacillus paracasei subsp. paraca-sei F19 in association with vaginal suppositories of Lactobacillus acidofilus in the treatment of vaginosis and in the prevention of recurrent vaginitis. Minerva Ginecol 2006 58 : 227 231.
92. Shalev E, Battino S, Weiner E, Colodner R, Keness Y. Ingestion of yogurt containing Lactobacillus aci-dophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med 1996 5 : 593 596.
93. Pattman RS, Sankar KN, Watson PG, Wardropper AG. An audit of Gynatren (a Lactobacillus aci-dophilus lyophilisate) vaccination in women with recurrent bacterial vaginosis. Int J STD AIDS 1994 5 : 299.
94. Reid G. Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 2001 73 : 437 443.
95. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing entero-colitis in preterm infants. A prospective double-blind study. Biol Neonate 2002 82 : 103 108.
96. Bruce AW, Reid G. Intravaginal instillation of lac-tobacilli for prevention of recurrent urinary tract infection. Can J Microbiol 1988 34 : 339 343.
97. Reid G, Bruce AW, Taylor M. Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther 1992 14 : 11 16.
98. Nishijima K, Shukunami K, Kotsuji F. Probiotics affects vaginal flora in pregnant women, suggesting the possibility of preventing preterm labor. J Clin Gastroenterol 2005 39 : 447 448.
99. Watts DH, Fazzari M, Minkoff H, et al. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-unin-fected women. J Infect Dis 2005 191 : 1129 1139.
100. Bauer G. Lactobacilli-mediated control of vaginal cancer through specific reactive oxygen species interaction. Med Hypotheses 2001 57 : 252 257.
101. Klimek R. Induction and stimulation of immuno-logic defenses with Gynatren (Solco Trichovas) as an example of cause-related prevention and treatment of neoplasms. Ginekol Pol 1987 58 : 552 555.
102. Last JM. Scope and method of prevention. In : Last JM, Wallace RB, eds. Maxcy-Rosenau-Last Public Health and Prevention Medicine. 13th ed. Norwalk, CT : Appleton & Lange 1992 : 11 39.
103. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000 30 : 1604 1610.
104. Viljanen M, Savilahti E, Haahtela T, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 2005 60 : 494 500.
105. Rosenfeldt V, Benfeldt E, Nielsen SD, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. JACI 2003 111 : 389 395.
106. Brouwer ML, Wolt-Plompen SAA, Dubois AEJ, et al. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 2006 36 : 899 906.
107. Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr 2003 36 : 223 227.
108. Wang MF, Lin HC, Wang YY, Hsu CH. Treatment of perennial allergic rhinitis with lactic acid bace-teria. Clin Exp Ped Allergy Immunol 2004 15 : 152 158.
109. Xiao JZ, Kondo S, Yanagisawa N, et al. Effect of probiotic Bifidobacterium longum BBS36 in relieving clinical symptoms and modulating plasma cy-tokine levels of Japanese cedar pollinosis during the pollen season. A randomized double-blind, placebo controlled trial. J Investig Allergol Clin Immunol 2006 16 : 86 93.
110. Helin T, Haahtela S, Haahtela T. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 2002 57 : 243 246.
111. Wheeler JG, Shema SJ, Bogle ML, et al. Immune and clinical impact of Lactobacillus acidophilus on asthma. Ann All Asthma Immunol 1997 79 : 229 233.
112. Crane J. Asthma and allergic diseases: is there a downside to cleanliness Eur J Clin Nutr 2002 56 : 39 43.
113. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003 361 : 1869 1871.
114. Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002 109 : 119 121.
115. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001 357 : 1076 1079.
116. de Vrese M, Winkler P, Rautenberg P, et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr 2005 24 : 481 491.
117. Winkler P, de Vrese M, Laue C, Schrezenmeir J. Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. Int J Clin Pharmacol Ther 2005 43 : 318 326.
118. Hatakka K, Savilahti E, Ponka A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 2001 322 : 1 5.
119. Schiffrin EJ, Brassart D, Servin AL, Rochat F, Don-net-Hughes A. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr 1997 66 : 515 520.
120. Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr 2000 54 : 263 267.
121. Chiang BL, Sheih YH, Wang LH, Liao CK, Gill HS. Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. Eur J Clin Nutr 2002 54 : 849 855.
122. Gill HS, Cross ML. Probiotics and immune function. In : Calder P, Fields C, Gill HS, eds. Nutrition and Immune Function. Wallingford, UK : CABI Publishing 2002 : 251 272.
123. Gluck U, Gebbers JO. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneu-moniae, and beta-hemolytic streptococci). Am J Clin Nutr 2003 77 : 517 520.
124. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992 32 : 141 144.
125. Roos K, Holm SE, Grahn-Hakansson E, Lagergren L. Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyn-gotonsillitis - a randomized placebo-controlled multicentre study. Scand J Infect Dis 1996 28 : 459 462.
126. Falck G, Grahn-Hakansson E, Holm SE, Roos K, Lagergren L Tolerance and efficacy of interfering alpha-streptococci in recurrence of streptococcal pharyngotonsillitis: a placebo-controlled study. Acta Otolaryngol 1999 119 : 944 948.
127. Roos K, Hakansson EG, Holm S. Effect of recolo-nisation with "interfering" alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial. BMJ 2001 27 322 : 210 212.
128. Brook I. The role of bacterial interference in otitis, sinusitis and tonsillitis. Otolaryngol Head Neck Surg 2005 133 : 139 146.
129. Agren K, Lundberg C, Nord CE. Effect of amoxy-cillin/clavulanic acid on the aerobic and anaerobic tonsillar microflora in the treatment of recurrent tonsillitis. Scand J Infect Dis 1990 22 : 691 697.
130. Brook I, Gober AE. Bacterial interference in the nasopharynx following antibiotic therapy of acute otitis media. J Antimicrob Chemother 1998 41 : 489 492.
131. Rosenfeldt V, Vesikari T, Pang XL, Zeng SQ, Tvede M, Paerregaard A. Viral etiology and incidence of acute gastroenteritis in young children attending day-care centers. Pediatr Infect Dis J 2005 24 : 962 965.
132. Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002 109 : 678 684.
133. Weizman Z, Asli G, Alsheikh A. Effects of a probi-otic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 2005 115 : 5 9.
134. Pedone CA, Arnaud CC, Postaire ER, Bouley CF, Reinert P. Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea. Int J Clin Pract 2000 54 : 568 571.
135. Pedone CA, Bernabeu AO, Postaire ER, Bouley CF, Reinert P. The effect of supplementation with milk fermented by Lactobacillus casei (strain DN 114 001) on acute diarrhoea in children attending day care centres. Int J Clin Pract 1991 53 : 179 184.
136. Carabin H, Gyorkos TW, Soto JC, Penrod J, Josheph L, Collet JP. Estimation of direct and indirect costs because of common infections in toddlers attending day care centers. Pediatrics 1999 103 : 556 564.
137. Brady MT. Infectious disease in pediatric out-of-home child care. Am J Infect Control 2005 33 : 276 285.
138. Kahan E, Gross S, Horev Z, Grosman Z, Cohen HA. Pediatrician attitudes to exclusion of ill children from child-care centers in Isreal: pressure on ambulatory practices. Patient Educ Couns 2006 60 : 164 170.
139. Turchet P, Laurenzano M, Auboiron S, Antoine JM. Effect of fermented milk containing the probiotic Lactobacillus casei DN 114 001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. J Nutr Health Aging 2003 7 : 75 77.
140. Tubelius P, Stan V, Zachrisson A. Increasing workplace healthiness with the probiotic Lactobacillus reuteri: a randomised double-blind placebo-controlled study. Environ Health 2005 4 : 25.
141. Lubianca Neto JF, Hemb L, Silva DB. Systematic literature review of modifiable risk factors for recurrent acute otitis media in childhood. J Pediatr 2006 82 : 87 96.
142. Curry MD. Costs of otitis media. Pediatrics 2000 105 : 156 157.
143. Hatakka K, Mario J, Korpela M, et al. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis - a pilot study. Scand J Rheumatol 2003 32 : 211 215.